¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Congenital viral hepatitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • congenital hereditary hearing loss
    ¼±ÃµÀ¯Àü³­Ã»
  • congenital hypoplastic anemia
    ¼±ÃµÀúÇü¼ººóÇ÷
  • congenital laryngeal stridor
    ¼±ÃµÈĵα׷·°Å¸²
  • congenital megacolon
    ¼±Ãµ°Å´ëÀß·ÏâÀÚ, ¼±Ãµ°Å´ë°áÀå
  • congenital nonbullous icthyosiform erythroderma
    ¼±Ãµºñ¹°Áýºñ´ÃÁõ¸ð¾çÈ«»öÇǺÎ(Áõ), ¼±Ãµºñ¼öÆ÷ºñ´ÃÁõ¸ð¾çÈ«»öÇǺÎ(Áõ)
  • congenital oculomotor apraxia
    ¼±ÃµÈ´º¸±â¸øÇÔ(Áõ), ¼±ÃµÈ´º¸±â½ÇÇàÁõ
  • congenital preauricular fistula
    ¼±Ãµ±Ó¹ÙÄû¾Õ»û±æ, ¼±ÃµÀÌÀüºÎ´©°ø
  • congenital rubella syndrome
    ¼±ÃµÇ³ÁøÁõÈıº
  • congenital syphilis
    ¼±Ãµ¸Åµ¶
  • congenital torticollis
    ¼±Ãµ±â¿î¸ñ, ¼±Ãµ»ç°æ
  • congenital toxoplasmosis
    ¼±ÃµÅå¼ÒÆ÷ÀÚÃæÁõ
  • congenital word deafness
    ¼±Ãµ¸»±Í¸ÔÀ½, ¼±Ãµ¾î³ó
  • anicteric hepatitis
    ¹«È²´Þ°£¿°
  • autoimmune hepatitis
    ÀÚ°¡¸é¿ª°£¿°
  • acute hepatitis
    ±Þ¼º°£¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • congenital nonbullous icthyosiform erythroderma
    ¼±Ãµºñ¹°Áýºñ´ÃÇǺÎÁõ¸ð¾çÈ«»öÇǺÎÁõ
  • congenital preauricular fistula
    ¼±Ãµ±Ó¹ÙÄû¾Õ»û±æ, ¼±ÃµÀÌÀüºÎ´©°ø
  • congenital telangiectatic erythema
    ¼±Ãµ¸ð¼¼Ç÷°üÈ®ÀåÈ«¹Ý
  • congenital word deafness
    ¼±Ãµ¸»±Í¸ÔÀ½
  • discrete subvalvular congenital aortic stenosis
    ºÐ¸®¼±ÃµÆÇ¸·¹Ø´ëµ¿¸ÆÇùÂøÁõ
  • giant congenital pigmented nevus
    ¼±Ãµ°Å´ë»ö¼ÒÄ§Âø¸ð¹Ý
  • alcoholic hepatitis
    ¾ËÄڿ𣿰
  • amebic hepatitis
    ¾Æ¸Þ¹Ù°£¿°
  • anicteric hepatitis
    ¹«È²´Þ°£¿°
  • autoimmune hepatitis
    (¢¡chronic active hepatitis) ¸¸¼ºÈ°µ¿°£¿°
  • hepatitis B core antigen
    ºñÇü°£¿°ÇÙ½ÉÇ׿ø
  • hepatitis B surface antigen
    ºñÇü°£¿°Ç¥¸éÇ׿ø
  • cholangiolitic hepatitis
    (¢¡cholestatic hepatitis) ´ãÁóÁ¤Ã¼°£¿°
  • cholestatic hepatitis
    ´ãÁóÁ¤Ã¼°£¿°
  • chronic active hepatitis
    ¸¸¼ºÈ°µ¿°£¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • anicteric hepatitis
    ¹«È²´Þ¼º °£¿°.
  • antigen, hepatitis B core
    BÇü °£¿°¹ÙÀÌ·¯½º ÇÙ½ÉÇ׿ø
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • granulomatous hepatitis
    À°¾ÆÁ¾¼º °£¿°.
  • gummatous hepatitis
    °í¹«Á¾¼º °£¿°.
  • hemorrhagic hepatitis
    ÃâÇ÷(¼º) °£¿°.
  • hepatitis
    °£¿°(ÊÜæú).
  • hepatitis A virus(HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis A virus (HAV)
    AÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis B core antigen (HBc Ag)
    BÇü °£¿°¹ÙÀÌ·¯½º ÇÙ½ÉÇ׿ø
  • hepatitis B surface antigen (HBs Ag)
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • hepatitis B surface antigen(HBs Ag)
    BÇü °£¿°Ç¥¸éÇ׿ø
  • hepatitis B virus(HBV)
    BÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis C virus(HCV)
    CÇü °£¿°¹ÙÀÌ·¯½º
  • hepatitis D coinfection
    D Çü °£¿°µ¿½Ã°¨¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • viral disease
    ¹ÙÀÌ·¯½ºº´(Áúȯ)
  • viral dysentery
    ¹ÙÀÌ·¯¼º ÀÌÁú(¡­ì¸òð).
  • viral encephalitides
    ¹ÙÀÌ·¯½º³ú¿°±º (¡­ÒàæúÏØ).
  • viral encephalitides
    ¹ÙÀÌ·¯½º³ú¿°±º (¡­ÒàæúÏØ)
  • viral encephalitis
    ¹ÙÀÌ·¯½º¼º ³ú¿°
  • viral encephalitis
    ¹ÙÀÌ·¯½º³ú¿°.
  • viral encephalitis
    ¹ÙÀÌ·¯½º³ú¿°
  • viral exanthem
    ¹ÙÀÌ·¯½º¼º ¹ßÁø
  • viral exanthem
    ¹ÙÀÌ·¯½º¼º ¹ßÁø.
  • viral gastroenteritis
    ¹ÙÀÌ·¯½º¼º À§Àå¿°(¡­êÖ æú).
  • viral genetics
    ¹ÙÀÌ·¯½ºÀ¯ÀüÇÐ(¡­ë¶îîùÊ).
  • viral hemagglutination
    ¹ÙÀÌ·¯½º Ç÷±¸ ÀÀÁý¹ý
  • viral hemorrhagic fever
    ¹ÙÀÌ·¯½º¼º ÃâÇ÷¿­(¡­õóúìæð).
  • viral inclusion
    ¹ÙÀÌ·¯½º¼º ºÀÀÔ(ü)
  • viral infection
    ¹ÙÀÌ·¯½º¼º °¨¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CHA Canadian Hospital Association; Catholic Health Association; Chinese hamster; chronic hemolytic anemi...
CHD Chediak-Higashi disease; childhood disease; chronic hemodialysis; congenital or congestive heart dis...
CAH   1) Chronic Active Hepatitis
  2) Congenital Adrenal Hyperplasia
CHB chronic hepatitis B; complete heart block; congenital heart block
HA H antigen; Hakim-Adams [syndrome]; halothane anesthesia; Hartley [guinea pig]; headache; health alli...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BVD-MD Bovine viral diarrhea-mucosal disease
ev Endogenous viral
EBV Epstein Barr viral
HSV Herpes Simplex Viral
PVL Plasma viral load
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • viral meningitis
    ¹ÙÀÌ·¯½º ¼ö¸·¿°, ¹ÙÀÌ·¯½º¼º ¼ö¸·¿°
  • viral origin
    ¹ÙÀÌ·¯½º ±â¿ø, ¹ÙÀÌ·¯½º¼º ±â¿ø
  • viral pneumonia
    ¹ÙÀÌ·¯½º Æó·Å, ¹ÙÀÌ·¯½º¼º Æó·Å
  • viral respiratory disease
    ¹ÙÀÌ·¯½º È£Èí±â Áúȯ, ¹ÙÀÌ·¯½º¼º È£Èí±â Áúȯ
  • viral strain
    ¹ÙÀÌ·¯½º ÁÖ
  • viral wart
    ¹ÙÀÌ·¯½º¼º »ç¸¶±Í
    1. ¹ÙÀÌ·¯½º°¡ »óÇÇ¿¡¼­ ¾ç¼º Áõ½Ä ½Ã ÈçÈ÷ ³ªÅ¸³­´Ù. 2. º´º¯. ½ÉÇÑ ÀÚ±â Á¦¾îÀû »óÇÇÀÇ Áõ½Ä. ¼º¼÷ÇÑ »óÇǼ¼Æ÷ÀÇ ¼¼Æ÷º´Àû º¯È­. ÇöÀúÇÑ ´Ü ÇÙ±¸ÀÇ ÁöÁú ¹× ±âÀúÃþÀ¸·ÎÀÇ ¿°Áõ¼º ħÀ±.
  • acyanotic congenital cardiopathy
    ºñû»ö¼º ¼±Ãµ ½Éº´Áõ, ºñû»ö¼º ¼±Ãµ ½ÉÀ庴Áõ
  • bullous congenital icthyosiform erythroderma
    ¼öÆ÷¼º ¼±Ãµ¼º ¾î¸°¼±»ó È«ÇÇÁõ
  • congenital abducens-facial paralysis
    ¼±Ãµ¼º ¿ÜÀü ¾È¸é ½Å°æ¸¶ºñ
    µ¿ÀǾî=Mobius syndrome.
  • congenital absence
    ¼±Ãµ¼º °á¿©, ¼±Ãµ¼º °á¿©Áõ
  • congenital allergy
    ¼±Ãµ¼º ¾Ë·¹¸£±â
  • congenital alveolar dysplasia
    ¼±Ãµ¼º ÆóÆ÷ ÀÌÇü¼º, ¼±Ãµ¼º ÆóÆ÷ ÀÌÇü¼ºÁõ
  • congenital amputation
    ¼±Ãµ¼º Àý´Ü, ÀÚ¿¬ Àý´Ü
    µ¿ÀǾî=natural am
  • congenital and developmental bone disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º °ñ Àå¾Ö
  • congenital and developmental muscle disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º ±ÙÀå¾Ö
    Ãâ»ý ½ÃºÎÅÍ ±ÙÀúÇϸ¦ ³ªÅ¸³»°í Èå´ÃÈå´ÃÇÑ ¾ÆÀÌ. flo
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
viral envelope proteins Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
(12 Dec 1998)
viral fusion proteins Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells.
(12 Dec 1998)
viral gastroenteritis <pathology> An inflammatory condition of the intestines that results from an infection with a virus. Rotavirus is a common cause. Abdominal pain, diarrhoea, nausea and vomiting are common symptoms.
(27 Sep 1997)
viral haemagglutination The nonimmune agglutination of suspended red blood cells by certain of a wide range of otherwise unrelated viruses, usually by the virion itself but in some instances by products of viral growth, the species of erythrocyte agglutinated differing with the different viruses.
See: haemagglutination inhibition.
(05 Mar 2000)
viral haemorrhagic fever An epidemic viral illness seen in southern Sudan and Zaire, caused by the Ebola virus. The illness is characterised by fever, malaise, muscle aches, respiratory symptoms, diarrhoea, vomiting, epistaxis, haemoptysis, haematemesis, rash, tremors and subconjunctival haemorrhages. Transmitted by close bodily contact with infected individuals (blood, faeces and body fluids). Incubation is-21 days with initial symptoms of fever and headache. There is no specific treatment and death can occur within 10 days.
(27 Sep 1997)
viral haemorrhagic fever virus <virology> An epidemic viral illness seen in southern Sudan and Zaire, caused by the Ebola virus. The illness is characterised by fever, malaise, muscle aches, respiratory symptoms, diarrhoea, vomiting, epistaxis, haemoptysis, haematemesis, rash, tremors and subconjunctival haemorrhages. Transmitted by close bodily contact with infected individuals (blood, faeces and body fluids). Incubation is-21 days with initial symptoms of fever and headache. There is no specific treatment and death can occur within 10 days.
(27 Sep 1997)
viral infection The successful invasion, establishment and growth of viruses in the tissues of the host.
(27 Sep 1997)
viral interference A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus.
(12 Dec 1998)
viral load The number of viral particles (usually HIV) in a sample of blood plasma. HIV viral load is increasingly employed as a surrogate marker for disease progression. It is measured by PCR and bDNA tests and is expressed in number of HIV copies or equivalents per millilitre.
(09 Oct 1997)
viral matrix proteins Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.
(12 Dec 1998)
viral meningitis <pathology> A viral form of infection that is seen most often in those under 30 years of age. Peak time for infection is in late summer. Majority of cases are caused by the Coxsackie and echovirus.
(27 Sep 1997)
viral myocarditis <cardiology, virology> Inflammation of the heart muscle that is caused by an infection with a virus. Coxsackie B is most common in the U.S.A., but Coxsackie A, influenza, rubeola, rubella, Adenovirus, HIV and echovirus can all cause myocarditis.
(27 Sep 1997)
viral nonstructural proteins Viral proteins that are coded by nonstructural genes and usually have an unknown function. Some of these proteins may play structural roles within the infected cell during replication or act in virus regulation.
(12 Dec 1998)
viral oncogene <molecular biology> A viral gene that contributes to cancer development in vertebrate hosts.
(09 Oct 1997)
viral pericarditis Pericarditis due to a viral infection.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á